Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not ...

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

The age-old advice to "trust your gut" could soon take on new meaning for people diagnosed with Parkinson's disease, thanks to a creative feat of bioengineering by researchers in the University of ...

CDC reports show Ohio's Parkinson's death rate among adults 65 and older was lower than Utah's 102.1 per 100,000 but remains ...

Now, the personalized treatment is poised to touch millions of lives. Parkinson's disease diagnoses have doubled since the 1990s, affecting 10 million people around the world, including "Back to the ...

A major scientific revelation has ignited fresh optimism for the millions of people living with Parkinson’s disease worldwide. Researchers have successfully decoded the structure and activation ...

A study published in Cannabis and Cannabinoid Research examined the effects of medical cannabis on patients diagnosed with ...